[Beta blockers reduce mortality after myocardial infarct - also in COPD patients].
Horten-Zentrum für praxisorientierte Forschung und Wissenstransfer, Universitätsspital Zürich.
Stefan
S
Markun
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000368:Aged; D015331:Cohort Studies; D015897:Comorbidity; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality*; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy* / Q000401:mortality*; D015996:Survival Rate; D016896:Treatment Outcome; D006113:United Kingdom
D000319:Adrenergic beta-Antagonists